- VernacularTitle:中草药相关肝损伤的管理与治疗
- Author:
Xin SUN
1
;
Qiong LUO
1
;
Tao YANG
2
;
Chenghai. LIU
1
Author Information
- Publication Type:Journal Article
- Keywords: Drugs, Chinese Herbal; Chemical and Drug Induced Liver Injury; Therapeutics
- From: Journal of Clinical Hepatology 2024;40(8):1538-1542
- CountryChina
- Language:Chinese
- Abstract: Due to the diverse application forms of Chinese herbal medicine products, the wide range of users, and the complex conditions of medication in China, adverse events including herb-induced liver injury (HILI) occur frequently in recent years. In order to further understand HILI and standardize its risk management and prevention and treatment measures, this article discusses the risk management, clinical evaluation, prevention, and treatment of HILI based on related clinical research advances and experience in recent years. In the multiple links of traditional Chinese medicine including production and clinical application after marketing, the establishment of a comprehensive control system is of great importance for the prevention and treatment of HILI and other adverse events, involving product quality control, patient safety education, rational drug use by clinicians, regular monitoring, and graded and classified treatment, which provides a reference for the rational and safe clinical use of Chinese herbal medicine in the future.